New Biomarkers Could Revolutionize Early Autism Diagnosis, But Challenges Remain

Eye-Tracking Leads the Way

One of the most promising avenues for early autism diagnosis is eye-tracking technology. A study in JAMA Network Open published in May 2024 found that eye-tracking biomarkers, such as patterns of social attention, could help identify autism in primary care settings. This aligns with earlier research highlighted in Contemporary Pediatrics, which emphasized the potential of eye-tracking to bring autism diagnosis 'closer to home.'

Microbial Biomarkers: A New Frontier?

Another emerging area is the study of microbial and metabolite biomarkers—tiny organisms and their byproducts in stool and urine—that may differ in autistic individuals. A recent Nature study identified distinct microbial signatures associated with certain autism subgroups. However, factors like diet, antibiotics, or other medications can significantly alter these microbial communities, potentially skewing results. While a pilot study by CUHK and MicroSigX claims their AI-powered stool test can achieve over 95% accuracy in distinguishing autistic children (MobiHealthNews), these findings have not yet undergone rigorous peer review, a critical step for validating scientific claims.

AI and Digital Phenotyping: Decoding Behavior

AI and digital phenotyping—using technology to analyze behavior patterns—are also being explored. For example, a 2023 Nature study showed how AI could reduce false positives by analyzing subtle behavioral differences linked to autism. These tools might one day help pediatricians spot early signs during routine checkups, though they're not yet widely available.

The Road Ahead

While these advances are exciting, experts caution that most biomarker studies remain small-scale. Eye-tracking has the strongest evidence, with some tools already used in research clinics. Microbial tests, however, need independent validation across diverse populations. Implementation challenges include cost (eye-tracking systems can be expensive), accessibility (specialized training may be required), and standardization (ensuring consistent results across different labs). The ultimate goal is to pair these tools with clinical expertise to provide earlier, more precise diagnoses—like how blood tests complement a doctor's evaluation for other conditions.